POWELL, Ohio–(BUSINESS WIRE)–#ENFit –On October 12, 2021, the FDA released a safety communication after a singular field concern on dosing accuracy of the ENFit® LDT syringe. The Global Enteral Device ...
Azurity Pharmaceuticals’ Nymalize (nimodipine) oral solution in a 30mg/5ml prefilled ENFit syringe has received US Food and Drug Administration (FDA) approval. The ready-to-use prefilled syringe ...
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Enteral Syringes Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ...
Concerns about supply, dosing and blenderized diets are delaying the U.S. transition to a new standard for feeding tube connectors. The sweeping series of ISO 80369 standards were developed to prevent ...
WOBURN, Mass., Sept. 3, 2024 /PRNewswire/ -- Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the needs of overlooked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback